Drawing for ADMIRON LIFE SCIENCES PVT LTD

USPTO serial 88493799

ADMIRON LIFE SCIENCES PVT LTD

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PINO, BRIAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADMIRON LIFE SCIENCES PVT LTD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nick Craft

Nick Craft LEGALFORCE RAPC WORLDWIDE, P.C.446 E SOUTHERN AVETEMPE, AZ 85282UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the treatment of allergies, diabetes, asthma, osteoporosis and pain, nausea and vertigo; Analgesics; Antibiotics; Anti-hypertensives; Diarrhea medication; Anti-bacterial preparations, namely, medicated ointments for use on the skin; Cardiovascular treatment preparations; Nutritional supplements; Pharmaceutical preparations, namely, haemostatics; Sleep inducers, namely, sleeping pills; Laxatives; Pharmaceutical preparations for acting on the central nervous system; Stimulants for respiratory purposes; Anti-histamines, anti-inflammatory and anti-arthritic preparations; Food for babies; Medical plasters and dressings; Materials for stopping teeth and dental wax; Disinfectants, namely, all purpose disinfectants; Non medicated food supplements and dietary food supplements for human consumption, namely, anti-oxidants, vitamins, mineral supplements, amino acids for nutritional purposesACTIVE—
040Custom manufacture of pharmaceuticals by pharmaceutical compoundersACTIVE—
042Development of pharmaceutical preparations and medicines; Technical research in the field of pharmaceutical studies; Technical consulting in the field of pharmaceutical studies; Research on the subject of pharmaceuticals; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Laboratory research services relating to pharmaceuticals; Pharmaceutical research and development; Pharmaceutical products development; Testing of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 27, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 27, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 30, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 30, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 3, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 3, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 3, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 3, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 3, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 24, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 29, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 29, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 9, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 25, 2019ALIEASSIGNED TO LIE—
Sep 23, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 23, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Sep 23, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 23, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 23, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 17, 2019DOCKASSIGNED TO EXAMINER—
Jul 10, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 9, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 2, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance